← Leaderboards
Rajeev S Samant
University Of Alabama At Birmingham
$3,142,487
Attributed
$3,142,487
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $336.3K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,142,487 · 3
VA$0 · 1
By mechanism
R01$2,993,987 · 2
R03$148,500 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Craig A Elmets$8,601,504
- Jeevan Kumar Prasain$1,001,113
- Kristi Crowe$7,500
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionTumorBreast Cancer CellMalignant Breast NeoplasmMammary NeoplasmsPathway InteractionsTumor ProgressionNeoplastic CellCellsEventCancer CellMalignant NeoplasmsProteinsNeoplasm MetastasisInhibitor/AntagonistSpecimenMesenchymalSiteTumor GrowthGenetic TranscriptionInvadedBreast Cancer MetastasisDisease ProgressionDrug Resistance
Grant awards (20)
A novel strategy to debilitate breast cancer metastasis$74,250
R03 · FY2024 · CA · contact PI
Mechanisms that impact metastatic progression of triple negative breast cancer$0
I01 · FY2024 · VA · contact PI
Mechanisms that impact metastatic progression of triple negative breast cancer$0
I01 · FY2023 · VA · contact PI
A novel strategy to debilitate breast cancer metastasis$74,250
R03 · FY2022 · CA · contact PI
Mechanisms that impact metastatic progression of triple negative breast cancer$0
I01 · FY2022 · VA · contact PI
Mechanisms that impact metastatic progression of triple negative breast cancer$0
I01 · FY2021 · VA · contact PI
Dietary intervention of non-classical Wnt signaling$336,263
R01 · FY2020 · CA · contact PI
Impact of N-Myc interactor on metastatic progression of breast cancer.$0
I01 · FY2020 · VA · contact PI
Dietary intervention of non-classical Wnt signaling$326,174
R01 · FY2019 · CA · contact PI
Impact of N-Myc interactor on metastatic progression of breast cancer.$0
I01 · FY2019 · VA · contact PI
Dietary intervention of non-classical Wnt signaling$336,263
R01 · FY2018 · CA · contact PI
Impact of N-Myc interactor on metastatic progression of breast cancer.$0
I01 · FY2018 · VA · contact PI
Dietary intervention of non-classical Wnt signaling$336,263
R01 · FY2017 · CA · contact PI
Impact of N-Myc interactor on metastatic progression of breast cancer.$0
I01 · FY2017 · VA · contact PI
Dietary intervention of non-classical Wnt signaling$336,263
R01 · FY2016 · CA · contact PI
Role of Nmi in retarding breast tumor growth.$258,300
R01 · FY2014 · CA · contact PI
Role of Nmi in retarding breast tumor growth.$249,672
R01 · FY2013 · CA · contact PI
Role of Nmi in retarding breast tumor growth.$269,005
R01 · FY2012 · CA · contact PI
Role of Nmi in retarding breast tumor growth.$269,005
R01 · FY2011 · CA · contact PI
Role of Nmi in retarding breast tumor growth.$276,779
R01 · FY2010 · CA · contact PI